NovaBay Pharmaceuticals Inc. (NYSE AMERICAN: NBY) Stock Information | RedChip

NovaBay Pharmaceuticals Inc. (NYSE AMERICAN: NBY) Listen to this Section


$0.53
+0.0428 ( +8.70% ) 702.8K

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically eyecare and skincare products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease. It has two reportable segments: Eyecare and Wound Care and Skincare.

Market Data


Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 May 30, 2024
4 Insider transactions 1 May 30, 2024
4 Insider transactions 1 May 30, 2024
8-k 8K-related 16 May 29, 2024
10-q Quarterly Reports 92 May 09, 2024
8-k 8K-related 37 Apr 22, 2024
8-k 8K-related 16 Apr 19, 2024
def Proxies and info statements 27 Apr 18, 2024
ars Annual reports 1 Apr 18, 2024
pre Proxies and info statements 28 Apr 08, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.